+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-10-21Number of Pages: 165

Bovine Respiratory Disease Treatment Market (Treatment Type - Vaccines, Antibiotics, NSAIDs, and Immunomodulators; Disease Type - Upper Respiratory Tract Infections, Pneumonia (Lower Respiratory Tract Infection), and Diphtheria; Distribution Channel - Veterinary Hospitals, Veterinary Clinics, Private Veterinary Pharmacies, and Veterinary Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Bovine Respiratory Disease Treatment Market: Snapshot

Bovine respiratory disease (BRD) is a commonly occurring respiratory disorder among cattle, which may result from a single or a number of factors combined. The disease has been gaining much attention of late as it significantly impacts the global beef industry. As a result, the prevention as well as treatment of bovine respiratory disease is necessary in order to mitigate its impact on animal production and the overall beef industry.

The bovine respiratory disease treatment market is projected to expand at a strong pace in terms of revenue in the coming years, thanks to rising consumption of animal protein among the human population, increasing cattle population, and a number of environmental factors. Transparency Market Research finds that the global market for bovine respiratory disease treatment will grow from US$805.9 mn in 2015 to US$1543.9 mn by 2024, and projected to expand at a CAGR of 7.6% therein. 

bovine respiratory disease treatment market

Veterinary Hospitals Account for Dominant Share in Bovine Respiratory Disease Treatment Market

By way of disease type, upper respiratory tract infections held the leading share in the global bovine respiratory disease treatment market in terms of revenue in 2015. The key causative agents of upper respiratory tract infections include infectious m.haemolytica, bovine rhinotracheitis, and type 1 bovine herpesvirus. Diphtheria and lower respiratory tract infection, or pneumonia, also accounted for a prominent share that year.

Based on distribution channel, the global bovine respiratory disease treatment market includes veterinary clinics, veterinary hospitals, veterinary research institutes, and private veterinary pharmacies. Veterinary hospitals dominated the market in 2015 in terms of revenue owing to factors such as increasing population of bovine, which is likely to increase the chances of respiratory diseases among cattle. Moreover, since most of the procedures are carried out in veterinary hospitals, this segment will continue to gain much traction.

Also exhibiting strong potential during the course of the forecast period is the private veterinary pharmacies segment, which is projected to register a significant CAGR through 2024, especially in most of the emerging parts of the world. In addition to this segment, the veterinary research institutes and veterinary clinics segments will also grow steadily.

Powered by U.S., North America Leads Global Market

From a geographical point of view, the bovine respiratory disease treatment market has been segmented into: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America accounts for a major share in the global market, of which around 90% is held by the U.S. alone. The bovine respiratory disease treatment market in the U.S. is propelled by the rising domestic production, consumption, and export of bovine meat.

Europe has also been a major contributor to this market and is fueled by the growing prevalence of several causative agents for respiratory diseases among bovines, rapidly changing environmental factors, and expanding cattle population, which is driven by the rising demand for better quality bovine meat and products. Asia Pacific is likely to emerge as a highly lucrative market for bovine respiratory disease treatment as it is the leading producer of bovine livestock. The market in Asia Pacific is projected to expand at a CAGR of 8.2% from 2016 to 2024, with the demand for bovine respiratory disease treatment products significantly high in China, India, and Australia.

Bayer AG, Elanco, Vetoquinol, Merial, Zoetis Services LLC, Ceva, Boehringer Ingelheim GmbH, Merck & Co., Inc., Bimeda Animal Health, and Virbac Group are some of the top companies in this space. Despite the fact that there are a large number of players operating in the global bovine respiratory disease treatment market, the vendor landscape is highly consolidated and this has resulted in a high degree of competition.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bovine Respiratory Disease Treatment Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Bovine Respiratory Disease Treatment Market Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunity
     4.4. Global Bovine Respiratory Disease Treatment Market Analysis and Forecasts, 2014 – 2024
            4.4.1. Pricing - Actuals and Projections, 2014 – 2024 (US$)
            4.4.2. Market Revenue Projections (US$ Mn)
     4.5. Bovine Respiratory Disease Treatment Market - Global Supply Demand Scenario
     4.6. Porter’s Five Force Analysis
     4.7. Value Chain Analysis
            4.7.1. List of active market participants (suppliers/distributors/manufacturers/vendors)
                     4.7.1.1. Product Manufacturers
                     4.7.1.2. Product Distributors
     4.8. Market Outlook

5. Global Bovine Respiratory Disease Treatment Market Analysis and Forecast, Disease Type
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Size (US$ Mn) Forecast, Disease Type,
                     5.4.1.1. Upper Respiratory Tract Infections
                     5.4.1.2. Diphtheria
                     5.4.1.3. Pneumonia (Lower Respiratory Tract Infection)
     5.5. Product Comparison Matrix
     5.6. Market Attractiveness, Disease Type , 2015

6. Global Bovine Respiratory Disease Treatment Market Analysis and Forecast, Treatment Type
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Size (US$ Mn) Forecast, Treatment Type,
            6.4.1. Vaccines
            6.4.2. Antibiotics
            6.4.3. NSAIDs
            6.4.4. Immunomodulators
            6.4.5. Others
     6.5. Product Comparison Matrix
     6.6. Market Attractiveness, Treatment Type , 2015

7. Global Bovine Respiratory Disease Treatment Market Analysis and Forecast, By Distribution Channel
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Size (US$ Mn) Forecast, By Distribution Channel,
            7.4.1. Veterinary Hospitals
            7.4.2. Veterinary Clinics
            7.4.3. Private Veterinary Pharmacies
            7.4.4. Veterinary Research Institutes
            7.4.5. Others
     7.5. Market Attractiveness, By Distribution Channel, 2015

8. Global Bovine Respiratory Disease Treatment Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market Size (US$ Mn) Forecast By Region
            8.3.1. North America
            8.3.2. Europe
            8.3.3. Asia Pacific
            8.3.4. Latin America
            8.3.5. Middle East and Africa
     8.4. Market Attractiveness By Country/Region

9. North America Bovine Respiratory Disease Treatment Market Analysis and Forecast
     9.1. Key Findings
     9.2. Policies and Regulations
     9.3. Market Size (US$ Mn) Forecast, Disease Type,
            9.3.1. Upper Respiratory Tract Infections
            9.3.2. Diphtheria
            9.3.3. Pneumonia (Lower Respiratory Tract Infection)
     9.4. Market Size (US$ Mn) Forecast, Treatment Type,
            9.4.1. Vaccines
            9.4.2. Antibiotics
            9.4.3. NSAIDs
            9.4.4. Immunomodulators
            9.4.5. Others
     9.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
            9.5.1. Veterinary Hospitals
            9.5.2. Veterinary Clinics
            9.5.3. Private Veterinary Pharmacies
            9.5.4. Veterinary Research Institutes
            9.5.5. Others
     9.6. Market Size (US$ Mn) Forecast, By Country
            9.6.1. US
            9.6.2. Canada
     9.7. Market Attractiveness Analysis 
            9.7.1. By Country
            9.7.2. Disease Type
            9.7.3. By Treatment Type
            9.7.4. By Distribution Channel

10. Europe Bovine Respiratory Disease Treatment Market Analysis and Forecast
     10.1. Key Findings
     10.2. Policies and Regulations
     10.3. Market Size (US$ Mn) Forecast, Disease Type,
            10.3.1. Upper Respiratory Tract Infections
            10.3.2. Diphtheria
            10.3.3. Pneumonia (Lower Respiratory Tract Infection)
     10.4. Market Size (US$ Mn) Forecast, Treatment Type,
            10.4.1. Vaccines
            10.4.2. Antibiotics
            10.4.3. NSAIDs
            10.4.4. Immunomodulators
            10.4.5. Others
     10.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
            10.5.1. Veterinary Hospitals
            10.5.2. Veterinary Clinics
            10.5.3. Private Veterinary Pharmacies
            10.5.4. Veterinary Research Institutes
            10.5.5. Others
     10.6. Market Size (US$ Mn) Forecast, By Country
            10.6.1. Germany
            10.6.2. UK
            10.6.3. Spain
            10.6.4. France
            10.6.5. Italy
            10.6.6. Rest of Europe
     10.7. Market Attractiveness Analysis 
            10.7.1. By Country
            10.7.2. Disease Type
            10.7.3. By Treatment Type
            10.7.4. By Distribution Channel

11. Asia Pacific Bovine Respiratory Disease Treatment Market Analysis and Forecast
     11.1. Key Findings
     11.2. Policies and Regulations
     11.3. Market Size (US$ Mn) Forecast, Disease Type,
            11.3.1. Upper Respiratory Tract Infections
            11.3.2. Diphtheria
            11.3.3. Pneumonia (Lower Respiratory Tract Infection)
     11.4. Market Size (US$ Mn) Forecast, Treatment Type,
            11.4.1. Vaccines
            11.4.2. Antibiotics
            11.4.3. NSAIDs
            11.4.4. Immunomodulators
            11.4.5. Others
     11.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
            11.5.1. Veterinary Hospitals
            11.5.2. Veterinary Clinics
            11.5.3. Private Veterinary Pharmacies
            11.5.4. Veterinary Research Institutes
            11.5.5. Others
     11.6. Market Size (US$ Mn) Forecast, By Country
            11.6.1. India
            11.6.2. China
            11.6.3. Japan
            11.6.4. Australia
            11.6.5. Rest of APAC
     11.7. Market Attractiveness Analysis 
            11.7.1. By Country
            11.7.2. Disease Type
            11.7.3. By Treatment Type
            11.7.4. By Distribution Channel

12. Latin America Bovine Respiratory Disease Treatment Market Analysis and Forecast
     12.1. Key Findings
     12.2. Policies and Regulations
     12.3. Market Size (US$ Mn) Forecast, Disease Type,
            12.3.1. Upper Respiratory Tract Infections
            12.3.2. Diphtheria
            12.3.3. Pneumonia (Lower Respiratory Tract Infection)
     12.4. Market Size (US$ Mn) Forecast, Treatment Type,
            12.4.1. Vaccines
            12.4.2. Antibiotics
            12.4.3. NSAIDs
            12.4.4. Immunomodulators
            12.4.5. Others
     12.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
            12.5.1. Veterinary Hospitals
            12.5.2. Veterinary Clinics
            12.5.3. Private Veterinary Pharmacies
            12.5.4. Veterinary Research Institutes
            12.5.5. Others
     12.6. Market Size (US$ Mn) Forecast, By Country
            12.6.1. Brazil
            12.6.2. Mexico
            12.6.3. Rest of LATAM
     12.7. Market Attractiveness Analysis 
            12.7.1. By Country
            12.7.2. Disease Type
            12.7.3. By Treatment Type
            12.7.4. By Distribution Channel

13. Middle East and Africa Bovine Respiratory Disease Treatment Market Analysis and Forecast
     13.1. Key Findings
     13.2. Policies and Regulations
     13.3. Market Size (US$ Mn) Forecast, Disease Type,
            13.3.1. Upper Respiratory Tract Infections
            13.3.2. Diphtheria
            13.3.3. Pneumonia (Lower Respiratory Tract Infection)
     13.4. Market Size (US$ Mn) Forecast, Treatment Type,
            13.4.1. Vaccines
            13.4.2. Antibiotics
            13.4.3. NSAIDs
            13.4.4. Immunomodulators
            13.4.5. Others
     13.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
            13.5.1. Veterinary Hospitals
            13.5.2. Veterinary Clinics
            13.5.3. Private Veterinary Pharmacies
            13.5.4. Veterinary Research Institutes
            13.5.5. Others
     13.6. Market Size (US$ Mn) Forecast, By Country
            13.6.1. South Africa
            13.6.2. Saudi Arabia
            13.6.3. UAE
            13.6.4. Rest of MEA
     13.7. Market Attractiveness Analysis 
            13.7.1. By Country
            13.7.2. Disease Type
            13.7.3. By Treatment Type
            13.7.4. By Distribution Channel

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)
     14.2. Market Share Analysis By Company (2015)
     14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.3.1. Global Market Players
                     14.3.1.1. Merck & Co., Inc.
                                 14.3.1.1.1. Company Overview
                                 14.3.1.1.2. Financial Overview
                                 14.3.1.1.3. Product Portfolio
                                 14.3.1.1.4. Business Strategies
                                 14.3.1.1.5. Recent Developments 
                     14.3.1.2. Zoetis Services LLC
                                 14.3.1.2.1. Company Overview
                                 14.3.1.2.2. Financial Overview
                                 14.3.1.2.3. Product Portfolio
                                 14.3.1.2.4. Business Strategies
                                 14.3.1.2.5. Recent Developments 
                     14.3.1.3. Bayer AG
                                 14.3.1.3.1. Company Overview
                                 14.3.1.3.2. Financial Overview
                                 14.3.1.3.3. Product Portfolio
                                 14.3.1.3.4. Business Strategies
                                 14.3.1.3.5. Recent Developments 
                     14.3.1.4. Elanco
                                 14.3.1.4.1. Company Overview
                                 14.3.1.4.2. Financial Overview
                                 14.3.1.4.3. Product Portfolio
                                 14.3.1.4.4. Business Strategies
                                 14.3.1.4.5. Recent Developments 
                     14.3.1.5. Merial
                                 14.3.1.5.1. Company Overview
                                 14.3.1.5.2. Financial Overview
                                 14.3.1.5.3. Product Portfolio
                                 14.3.1.5.4. Business Strategies
                                 14.3.1.5.5. Recent Developments 
                     14.3.1.6. Boehringer Ingelheim GmbH
                                 14.3.1.6.1. Company Overview
                                 14.3.1.6.2. Financial Overview
                                 14.3.1.6.3. Product Portfolio
                                 14.3.1.6.4. Business Strategies
                                 14.3.1.6.5. Recent Developments 
                     14.3.1.7. Virbac Group
                                 14.3.1.7.1. Company Overview
                                 14.3.1.7.2. Financial Overview
                                 14.3.1.7.3. Product Portfolio
                                 14.3.1.7.4. Business Strategies
                                 14.3.1.7.5. Recent Developments 
                     14.3.1.8. Ceva
                                 14.3.1.8.1. Company Overview
                                 14.3.1.8.2. Financial Overview
                                 14.3.1.8.3. Product Portfolio
                                 14.3.1.8.4. Business Strategies
                                 14.3.1.8.5. Recent Developments 
                     14.3.1.9. Vetoquinol
                                 14.3.1.9.1. Company Overview
                                 14.3.1.9.2. Financial Overview
                                 14.3.1.9.3. Product Portfolio
                                 14.3.1.9.4. Business Strategies
                                 14.3.1.9.5. Recent Developments 
                     14.3.1.10. Bimeda animal health
                                 14.3.1.10.1. Company Overview
                                 14.3.1.10.2. Financial Overview
                                 14.3.1.10.3. Product Portfolio
                                 14.3.1.10.4. Business Strategies
                                 14.3.1.10.5. Recent Developments 

List of Figures

Figure 01: Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Bovine Respiratory Disease Treatment Average Price (US$/ Treatment Type) 2014–2024
Figure 03: Market Value Share (%), by Disease Type (2015)
Figure 04: Market Value Share (%), by Treatment Type (2015)
Figure 05: Market Value Share (%), by End-user (2015)
Figure 06: Market Value Share (%), by Region (2015)
Figure 07: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Disease Type, 2015 and 2024
Figure 08: Global Upper Respiratory Tract Infections Market Size (US$ Mn), 2014–2024
Figure 09: Global Diphtheria Market Size (US$ Mn), 2014–2024
Figure 10: Global Pneumonia (lower respiratory tract infection) Market Size (US$ Mn), 2014–2024
Figure 11: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Disease Type, 2015
Figure 12: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Treatment Type, 2015 and 2024
Figure 13: Global Vaccines Market Size (US$ Mn), 2014–2024
Figure 14: Global Antibiotics Market Size (US$ Mn), 2014–2024
Figure 15: Global NSAIDs Market Size (US$ Mn), 2014–2024
Figure 16: Global Immunomodulators Market Size (US$ Mn), 2014–2024
Figure 17: Global Others Market Size (US$ Mn), 2014–2024
Figure 18: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Treatment Type, 2015
Figure 19: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 20: Global Veterinary Hospitals Market Size (US$ Mn), 2014–2024
Figure 21: Global Veterinary Clinics Market Size (US$ Mn), 2014–2024
Figure 22: Global Private Veterinary Pharmacies Market Size (US$ Mn), 2014–2024
Figure 23: Global Veterinary Research Institutes Market Size (US$ Mn), 2014–2024
Figure 24: Global Others Market Size (US$ Mn), 2014–2024
Figure 25: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 26: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Region, 2015 and 2024
Figure 27: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Region, 2015
Figure 28: U.S. Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 29: Canada Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 30: North America Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 31: North America Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 32: North America Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 33: North America Market Attractiveness Analysis, by Country, 2014–2024
Figure 34: Germany Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 35: U.K. Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 36: France Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 37: Spain Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 38: Italy Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 39: Rest of Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 40: Europe Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 41: Europe Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 42: Europe Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 43: Europe Market Attractiveness Analysis, by Country, 2014–2024
Figure 44: Japan Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 45: China Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 46: India Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 47: Australia Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 48: Rest of Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 49: Asia Pacific Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 50: Asia Pacific Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 51: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 52: Asia Pacific Market Attractiveness Analysis, by Country, 2014–2024
Figure 53: Brazil Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 54: Mexico Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 55: Rest of Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 56: Latin America Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 57: Latin America Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 58: Latin America Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 59: Latin America Market Attractiveness Analysis, by Country, 2014–2024
Figure 60: South Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 61: UAE Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 62: Rest of Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 63: Middle East & Africa Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 64: Middle East & Africa Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 65: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 66: Middle East & Africa Market Attractiveness Analysis, by Country, 2014–2024
Figure 01: Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Bovine Respiratory Disease Treatment Average Price (US$/ Treatment Type) 2014–2024
Figure 03: Market Value Share (%), by Disease Type (2015)
Figure 04: Market Value Share (%), by Treatment Type (2015)
Figure 05: Market Value Share (%), by End-user (2015)
Figure 06: Market Value Share (%), by Region (2015)
Figure 07: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Disease Type, 2015 and 2024
Figure 08: Global Upper Respiratory Tract Infections Market Size (US$ Mn), 2014–2024
Figure 09: Global Diphtheria Market Size (US$ Mn), 2014–2024
Figure 10: Global Pneumonia (lower respiratory tract infection) Market Size (US$ Mn), 2014–2024
Figure 11: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Disease Type, 2015
Figure 12: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Treatment Type, 2015 and 2024
Figure 13: Global Vaccines Market Size (US$ Mn), 2014–2024
Figure 14: Global Antibiotics Market Size (US$ Mn), 2014–2024
Figure 15: Global NSAIDs Market Size (US$ Mn), 2014–2024
Figure 16: Global Immunomodulators Market Size (US$ Mn), 2014–2024
Figure 17: Global Others Market Size (US$ Mn), 2014–2024
Figure 18: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Treatment Type, 2015
Figure 19: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 20: Global Veterinary Hospitals Market Size (US$ Mn), 2014–2024
Figure 21: Global Veterinary Clinics Market Size (US$ Mn), 2014–2024
Figure 22: Global Private Veterinary Pharmacies Market Size (US$ Mn), 2014–2024
Figure 23: Global Veterinary Research Institutes Market Size (US$ Mn), 2014–2024
Figure 24: Global Others Market Size (US$ Mn), 2014–2024
Figure 25: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2015

List of Tables

Table 01: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 02: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 03: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 04: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 05: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 06: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 07: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 08: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 09: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 10: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 11: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 12: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 13: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 14: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 15: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 16: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 17: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 18: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 19: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 20: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 21: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 22: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 23: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 24: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 01: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 02: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 03: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 04: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 05: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 06: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 07: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 08: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 09: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 10: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 11: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 12: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024

Global Bovine Respiratory Disease Treatment Market: Overview

Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, environmental factors, and direct influence of infectious agents such as virus, bacteria, and parasites. However, due to increasing consumption of milk and beef products, the need for bovine respiratory disease treatment has increased across the globe.

Moreover, according to the World Bank Group (2016), global human population is estimated to be 7.4 billion in 2016 and is growing at a rate of 1.8% per year. Hence, demand for beef has increased due to rising population and increasing disposable income across the world. The rising demand for high quality bovine derived products is influencing the bovine respiratory disease treatment market. Despite of innovations in veterinary medicines and advancement in technology, bovine respiratory disease is the leading cause to impact negatively on both the dairy and beef industries due to calf mortality, additional labor cost and treatment expenses. Moreover, bovine respiratory disease affects adversely on reproductive performance, growth and longevity of cattle. Hence, prevention and treatment of bovine respiratory disease have become important to decrease the impact on animal production and the beef industry. Therefore, the bovine respiratory disease treatment market is anticipated to witness significant growth in terms of revenue during the forecast period.

Global Bovine Respiratory Disease Treatment Market: Segmentation

In terms of treatment type, the bovine respiratory disease treatment market has been categorized into vaccines, antibiotics, NSAIDs, and immunomodulators. Causative agents such as viruses leading to bovine respiratory disease have no direct treatment. Hence, vaccination is the preferred choice of preventive action against the disease. This increase market potential for vaccines. However, virus infected cattle is exposed to bacteria, parasites, and various other factors. Therefore, antibiotics are the preferred choice of treatment for bovine respiratory diseases. Effective treatment and significant demand has increased the scope for antibiotics in the bovine respiratory disease treatment market.

However, according to NCBI report, combination treatment with anti-inflammatory drugs such as NSAIDs has better results over the monotherapy of antibiotics. This has led to increase in usage of NSAIDs in bovine respiratory disease treatment. Bovine respiratory disease is generally treated with several combination therapies. However, growing resistance to antibiotics and drying pipeline has increased demand for novel treatment options for which cattle do not develop resistance, and consequently there is no impact on human life.

Development of newer generation antibiotics for cattle is anticipated to drive the global bovine respiratory disease treatment market during the forecast period. In order to avoid the issue of antibiotics resistance in bovine population, preventive measures such as vaccination and immunomodulators has observed increased global acceptance against the bovine respiratory disease. Hence, preventive treatment is gaining momentum due to growing awareness about the negative impact of antibiotics on human health. This has driven the market for immunomodulators, vitamin injections, and other immunity building products.

In terms of disease type, the market has been segmented into upper respiratory tract infections, diphtheria, and pneumonia (lower respiratory tract infection). Upper respiratory tract infections dominated the global bovine respiratory disease market, accounting for significant share in terms of revenue in 2015. Respiratory infections first affect the upper respiratory tract, which is also the most vulnerable region, followed by other parts of the respiratory tract. Diphtheria accounted for significant share of the bovine respiratory disease treatment market in 2015. Pneumonia (lower respiratory tract infection) accounted for high market share, followed after upper respiratory tract infection in 2015. Hence, early detection of infection is important in bovine respiratory diseases treatment.

In terms of distribution channel, the global bovine respiratory disease treatment market has been segmented into veterinary hospitals, veterinary clinics, private veterinary pharmacies, and veterinary research institutes. Veterinary hospitals dominated the global bovine respiratory disease market in 2015. The segment dominated the market due to factors such as rising population of cattle which increases prevalence of bovine respiratory diseases. The private veterinary pharmacies distribution channel segment is projected to register significant CAGR during the forecast period. The segment is likely to witness strong growth in most of the emerging parts of the world and preference for medicines from private veterinary pharmacies for bovine serum respiratory diseases. However, the veterinary clinics and veterinary research institutes segments are expected to grow steadily as majority of procedures are carried out in veterinary hospitals.

Global Bovine Respiratory Disease Treatment Market: Geographical and Competitive Dynamics

Geographically, the bovine respiratory disease treatment market has been categorized in five major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America held the major share of the global bovine respiratory disease treatment market in 2015, where the U.S. dominates the market in terms of revenue. Europe accounted for a significant share of the market in 2015. Changing environmental factors, growing prevalence of causative agents for respiratory disease, increasing demand for quality bovine products, and rising bovine population are the key factors driving the bovine respiratory disease treatment market in Europe. Asia Pacific is the largest producer of bovine livestock. Hence, it presents significant opportunities in the bovine respiratory disease treatment market. India and China are the key markets for bovine respiratory disease treatment, as these have largest livestock population compared to other countries across the globe. Latin America and Middle East & Africa have comparatively smaller markets for bovine respiratory disease treatment. However, Brazil, Mexico, and Argentina are the emerging markets in Latin America due to significant number of livestock population.

Key players operating in the global bovine respiratory disease treatment market are Merck & Co., Inc., Zoetis Services LLC, Bayer AG, Elanco, Merial, Boehringer Ingelheim GmbH, Virbac Group, Ceva, Vetoquinol, and Bimeda Animal Health, among others.

The bovine respiratory disease treatment market has been segmented as follows:

Global Bovine Respiratory Disease Treatment Market, by Treatment Type

  • Vaccines
  • Antibiotics
  • NSAIDs
  • Immunomodulators
  • Others

Global Bovine Respiratory Disease Treatment Market, by Disease Type

  • Upper Respiratory Tract Infections
  • Diphtheria
  • Pneumonia (lower respiratory tract infection)

Global Bovine Respiratory Disease Treatment Market, by Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Private Veterinary Pharmacies
  • Veterinary Research Institutes
  • Others

Global Bovine Respiratory Disease Treatment Market, by Geography

  • North America
    • U.S.
    • Canada
    • Europe
  • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of APAC
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • North Africa
    • Rest of MEA
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America


 
 
Back To Top